Coller; Barry S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Coller; Barry S..The latest application filed is for "tetrahydronaphthyridinepentanamide integrin antagonists".
- Coller; Barry S. - New York NY
- Coller; Barry S - New York NY
- Coller; Barry S. - Dix Hills NY
| Patent | Date |
|---|---|
| Tetrahydronaphthyridinepentanamide integrin antagonists Grant 11,192,889 - Coller , et al. December 7, 2 | 2021-12-07 |
| Tetrahydronaphthyridinepentanamide Integrin Antagonists App 20200181138 - COLLER; Barry S. ; et al. | 2020-06-11 |
| Methods of treating sickle cell disease Grant 10,450,375 - Frenette , et al. Oc | 2019-10-22 |
| Methods of Treating Sickle Cell Disease App 20190153101 - Frenette; Paul S. ; et al. | 2019-05-23 |
| Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines Grant 9,532,989 - Coller , et al. January 3, 2 | 2017-01-03 |
| Controlled platelet activation to monitor therapy of ADP antagonists Grant 9,341,637 - Coller , et al. May 17, 2 | 2016-05-17 |
| 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders Grant 9,303,044 - Coller , et al. April 5, 2 | 2016-04-05 |
| Organic Compounds App 20150374697 - Coller; Barry S. ; et al. | 2015-12-31 |
| Alpha-IIb-beta-3 inhibitors and uses thereof Grant 9,073,945 - Blue , et al. July 7, 2 | 2015-07-07 |
| Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines Grant 9,066,948 - Coller , et al. June 30, 2 | 2015-06-30 |
| Organic Compounds App 20150050325 - Coller; Barry S. ; et al. | 2015-02-19 |
| Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists App 20140234859 - COLLER; Barry S. ; et al. | 2014-08-21 |
| Controlled platelet activation to monitor therapy of ADP antagonists Grant 8,574,828 - Coller , et al. November 5, 2 | 2013-11-05 |
| Organic Compounds App 20130251761 - Coller; Barry S. ; et al. | 2013-09-26 |
| Organic compounds App 20120190645 - Blue; Robert ; et al. | 2012-07-26 |
| Alpha-IIB-beta-3 inhibitors and uses thereof Grant 8,173,661 - Blue , et al. May 8, 2 | 2012-05-08 |
| Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists App 20110081657 - COLLER; Barry S. ; et al. | 2011-04-07 |
| Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists App 20110065125 - COLLER; Barry S. ; et al. | 2011-03-17 |
| Controlled platelet activation to monitor therapy of ADP antagonists Grant 7,790,362 - Coller , et al. September 7, 2 | 2010-09-07 |
| Organic Compounds App 20100150913 - Blue; Robert ; et al. | 2010-06-17 |
| Methods for measuring platelet reactivity of patients that have received drug eluting stents App 20070243632 - Coller; Barry S. ; et al. | 2007-10-18 |
| Methods of treating sickle cell disease App 20050112124 - Frenette, Paul S. ; et al. | 2005-05-26 |
| Controlled platelet activation to monitor therapy of ADP antagonists App 20050031616 - Coller, Barry S. ; et al. | 2005-02-10 |
| Methods of treating sickle cell disease App 20030198639 - Frenette, Paul S. ; et al. | 2003-10-23 |
| Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3 Grant 5,976,532 - Coller , et al. November 2, 1 | 1999-11-02 |
| Platelet-specific chimeric 7E3 immunoglobulin Grant 5,770,198 - Coller , et al. June 23, 1 | 1998-06-23 |
| Anti-aggregatory agents for platelets Grant 5,338,725 - Ojima , et al. August 16, 1 | 1994-08-16 |
| Method for preparing targeted carrier erythrocytes Grant 5,328,840 - Coller July 12, 1 | 1994-07-12 |
| Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi Grant 5,225,181 - Srivastava , et al. July 6, 1 | 1993-07-06 |
| NCAGE Code | 435N4 | COLLER BARRY S |
| CAGE Code | 435N4 | COLLER, BARRY S |
| DUNS | 603026084 | COLLER, BARRY S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 